-
Artemisinins are the most rapidly acting antimalarials available, have few serious side effects, and have been used extensively with few reports of resistance until recently.
-
Typhoid fever sickens more than 16 million people worldwide and causes up to 600,000 deaths annually, mostly in developing countries.
-
A randomized, double-blind, placebo-controlled, multicenter study was conducted from 2002-2006 at 25 institutions in France of the effect of prophylactic recombinant granulocyte-colony stimulating factor (rG-CSF) on nosocomial infections and survival among preterm neonates with persistent neutropenia.
-
The 2009 update of hiv primary care guidelines make several new recommendations, and the evidence basis for these is documented in the paper.
-
n this issue: WHO recommendations for antiviral use for H1N1 flu; antibiotic use trends for acute respiratory tract infection; denosumab clears FDA Expert Panel; FDA Actions.
-
-
Current recommendations for stroke prophylaxis with warfarin for patients with atrial fibrillation do not take into account the risks of hemorrhage.
-
Folke et al from Copenhagen, Denmark, studied the consequences of automatic external defibrillator (AED) placement in a large metropolitan area.
-
-
The ARMYDA (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) series of randomized, controlled trials has assessed the role of atorvastatin loading prior to percutaneous coronary intervention (PCI) in both stable and unstable coronary syndromes.
